Correlations between opioid mortality increases related to illicit/synthetic opioids and reductions of medical opioid dispensing - exploratory analyses from Canada

Bibliographic Data

ID15373521
AuthorsBenedikt Fischer (0000-0002-2186-4030, University of Auckland, corresponding author), Wayne Jones (0000-0001-8674-7946, Simon Fraser University), Mark Tyndall (0000-0003-4450-5679, University of British Columbia), Paul Kurdyak (0000-0001-8115-7437, Centre for Addiction and Mental Health)
Year2020
Volume20
Issue1
Pages143-143
Publication date2020-01-31
Peer ReviewedYes
Open AccessYes
TypeARTICLE
VenueBMC Public Health (JOURNAL)
Journal identifiersISSN: 1471-2458 • E-ISSN: 1471-2458
PublisherBioMed Central (PUBLISHER • GB)
DOI10.1186/s12889-020-8205-z
PMID32005211
OpenAlexW3013203641
LanguageEN
Citations received9
References cited28

Quasi-significant results indicate that recent increases in opioid-related deaths driven by illicit, synthetic opioids tended to be larger in provinces where reductions in prescription opioid availability have been more extensive. It is a plausible explanation that these reductions created supply gaps for non-medical opioid use increasingly filled by illicit, synthetic opioids differentially contributing to opioid-related deaths, generating un-intended adverse effects for previous interventions. General prevention measures to reduce opioid availability, and targeted prevention for at-risk opioid users exposed to toxic drug supply may be include counteractive effects and require coordinated reconciliation

Biostatistics · Medical emergency · Opioid · Opioid epidemic · Public health · Medicine · Nursing · Opioid Use Disorder Treatment · Prenatal Substance Exposure Effects · Substance Abuse Treatment and Outcomes · Emergency Medicine · Epidemiology · Internal Medicine